Navigation Links
BioreclamationIVT Signs Exclusive Agreement To Distribute Cellaria Cell Models And Media For Cancer Research
Date:4/13/2017

WESTBURY, N.Y., April 13, 2017 /PRNewswire/ -- BioreclamationIVT, a leading provider of biospecimens and related services, has signed a new distribution partnership agreement with Cellaria, LLC. According to the terms of the agreement, BioreclamationIVT will have exclusive market and distribution rights to Cellaria's novel cancer cell lines and cancer culture media in the United States and Canada and non-exclusive rights to sell the products globally. The agreement expands the availability of Cellaria's offerings to a broader range of potential customers via an established distribution partner with existing relationships inside the biopharmaceutical industry.

Designed to accelerate cancer research, the Cellaria cell models are derived directly from patient tumors with fully consented, fully documented pathological data. A unique feature of the cell models is their ability to maintain the fidelity of primary cells, with no genetic manipulation, while still offering the long-term reproducibility and scalability seen with traditional tumor cell lines. In addition to the cell lines, BioreclamationIVT will also distribute Cellaria's proprietary media which is specifically formulated to extend in vitro propagation of primary tumor and epithelial cells.  

David Deems, president of Cellaria Biosciences, said, "As a trusted partner to leading biopharmaceutical companies, BioreclamationIVT supports our goals of providing oncology researchers with more actionable data during their development of personalized therapeutics."

"Cellaria products represent an important addition to our rapidly growing disease-state matrices portfolio," said Jeff Gatz, CEO of BioreclamationIVT. "This distribution partnership leverages the strengths of both companies and ensures that we will continue to deliver relevant tools and services for our clients focused on disease research."

About Cellaria
Cellaria creates high-quality next generation in-vitro disease models that reflect the unique nature of a patient's biology. All of our models begin with tissue from a patient, capturing clinically relevant details that inform model characterization. For cancer, Cellaria's cell models exhibit molecular and phenotypic characteristics that are highly concordant to the patient. For RNA-mediated iPS cell line derivation, Cellaria's cell models enable interrogation of disease-specific mechanisms of action. Cellaria's innovative products and services help lead the research community to more personalized therapeutics – revolutionizing and accelerating the search for a cure. 

About BioreclamationIVT
BioreclamationIVT is a worldwide provider of biological products to the life sciences and pharmaceutical industries. BioreclamationIVT specializes in control and disease-state matrices manufactured from human and animal biological specimens and has recently expanded its offering to include cell processing and phenotypic screening services. This portfolio of products is utilized throughout the drug discovery and development research workflows, and directly supports the personalized medicine initiative by coupling clinical information with numerous disease-state fluids and tissues. BioreclamationIVT's reputation for providing exceptional customer service coupled with the highest quality specimens and services have made it the first-choice supplier for biospecimens for more than 35 years. For more information, please visit http://www.bioreclamationivt.com.

BioreclamationIVT Contact: Courtney Noah, Vice President of Marketing, 516-483-1196
Cellaria Contact: Tim Walsh, 617-512-1641, timw@walshgroupmarketing.com 
Media Contact: Lisa Osborne, Rana Healthcare Solutions, 206-992-5245, lisa@ranahealth.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bioreclamationivt-signs-exclusive-agreement-to-distribute-cellaria-cell-models-and-media-for-cancer-research-300439211.html


'/>"/>
SOURCE BioreclamationIVT
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Hemp, Inc. Signs Letter of Intent with One of Chinas Largest Agricultural Producers, Yasheng Group
2. Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
3. PharmaRoth Labs Signs Definitive Distribution Agreement in Mexico
4. Premier Healthcare Alliance [GPO] Re-Signs with Sysmex America, Inc. for 15th Consecutive Year
5. Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
6. Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard
7. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
8. MD Anderson Signs Contract For Pyxis ES Technology From CareFusion
9. Masimo Signs Far-Reaching Pulse Oximetry Distribution Deal with Butler Schein Animal Health
10. Five-Year SIMPONI Data Reported In Treatment Of Signs And Symptoms Of Moderately To Severely Active Rheumatoid Arthritis
11. Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2019)... ... 2019 , ... The American Legion Dorchester Post 91 in Cambridge, Md., donated ... the benefit of veteran patients, adding to a donation in the same amount it ... most recent donation from Post 91 will enable the VA Maryland Health Care System ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... Eye Movement Desensitization and Reprocessing therapy (EMDR). This therapeutic technique aims to reduce ... practice used for post-traumatic stress disorder (PTSD), depression, chronic pain, anxiety, and grief. ...
(Date:8/16/2019)... ... August 16, 2019 , ... Sacramento-based physician recruiting firm, ... States by Inc. magazine. MDstaffers three-year growth of more than 5,600 percent made ... fastest growing human resources company had it competed in this category. This news comes ...
Breaking Medicine Technology:
(Date:8/19/2019)... , ... August 19, 2019 , ... ... 12.5 million medically necessary and cosmetic procedures in 2018 – 7.5 percent more ... seventh year, the 2018 ASDS Survey on Dermatologic Procedures revealed skin ...
(Date:8/19/2019)... ... August 19, 2019 , ... Cosmetic Town, an online plastic surgery and ... restoration doctors in New York currently providing a lifetime of natural looking results for ... some thinning hair. Cosmetic Town makes the process of finding information about these board-certified ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. ... American economy’s most dynamic segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... from throughout the Mid-Atlantic and North East at the 2019 Safety Academy sponsored ... to build on existing construction safety concepts and define not only a safety ...
(Date:8/15/2019)... ... , ... With many students either starting college for the first time, and returning to school, ... CDC , “there are about 20 million new cases of STDs each year in ... 15 and 24. Young people are at greater risk of getting an STD.” To that ...
Breaking Medicine News(10 mins):